tradingkey.logo

Lantheus Holdings Inc

LNTH
65.120USD
+0.230+0.35%
交易中 美東報價延遲15分鐘
4.32B總市值
26.44本益比TTM

Lantheus Holdings Inc

65.120
+0.230+0.35%

關於 Lantheus Holdings Inc 公司

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus on cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, Neuraceq, and others. Its clinical candidates include LNTH-2404, NAV-4694, and PNT2002, among others. The Neuraceq (florbetaben F18 injection) is an F-18 PET imaging agent for Alzheimer’s disease.

Lantheus Holdings Inc簡介

公司代碼LNTH
公司名稱Lantheus Holdings Inc
上市日期Jun 25, 2015
CEOMarkison (Brian A)
員工數量808
證券類型Ordinary Share
年結日Jun 25
公司地址331 Treble Cove Road
城市NORTH BILLERICA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編01862
電話19786718001
網址https://www.lantheus.com/
公司代碼LNTH
上市日期Jun 25, 2015
CEOMarkison (Brian A)

Lantheus Holdings Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Ms. Mary Anne Heino
Ms. Mary Anne Heino
Executive Chairman of the Board, Interim Executive Officer
Executive Chairman of the Board, Interim Executive Officer
599.01K
+14285.00%
Mr. Brian A. Markison
Mr. Brian A. Markison
Chief Executive Officer, Director
Chief Executive Officer, Director
232.42K
+60654.00%
Dr. Jean-Claude Provost, M.D.
Dr. Jean-Claude Provost, M.D.
Chief Scientific Officer
Chief Scientific Officer
38.84K
-17901.00%
Dr. James H. (Jim) Thrall
Dr. James H. (Jim) Thrall
Independent Director
Independent Director
35.74K
+2537.00%
Dr. Gerard Ber, Ph.D.
Dr. Gerard Ber, Ph.D.
Independent Director
Independent Director
23.36K
+2141.00%
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
9.90K
+2537.00%
Dr. Phuong Khanh (P. K.) Morrow, M.D.
Dr. Phuong Khanh (P. K.) Morrow, M.D.
Independent Director
Independent Director
3.10K
+2537.00%
Mr. Samuel R. (Sam) Leno
Mr. Samuel R. (Sam) Leno
Independent Director
Independent Director
--
--
Ms. Julie H. Mchugh
Ms. Julie H. Mchugh
Lead Independent Director
Lead Independent Director
--
--
Mr. Gary John Pruden
Mr. Gary John Pruden
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Ms. Mary Anne Heino
Ms. Mary Anne Heino
Executive Chairman of the Board, Interim Executive Officer
Executive Chairman of the Board, Interim Executive Officer
599.01K
+14285.00%
Mr. Brian A. Markison
Mr. Brian A. Markison
Chief Executive Officer, Director
Chief Executive Officer, Director
232.42K
+60654.00%
Dr. Jean-Claude Provost, M.D.
Dr. Jean-Claude Provost, M.D.
Chief Scientific Officer
Chief Scientific Officer
38.84K
-17901.00%
Dr. James H. (Jim) Thrall
Dr. James H. (Jim) Thrall
Independent Director
Independent Director
35.74K
+2537.00%
Dr. Gerard Ber, Ph.D.
Dr. Gerard Ber, Ph.D.
Independent Director
Independent Director
23.36K
+2141.00%
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
9.90K
+2537.00%

收入明細

FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
PYLARIFY
240.62M
0.00%
DEFINITY
81.78M
0.00%
TechneLite
21.13M
0.00%
Neuraceq
20.44M
0.00%
Strategic partnerships and other
13.71M
0.00%
Other precision diagnostics
6.34M
0.00%
由於公司未披露,未能獲取相關數據
業務
地區
業務USD
名稱
營收
佔比
PYLARIFY
240.62M
0.00%
DEFINITY
81.78M
0.00%
TechneLite
21.13M
0.00%
Neuraceq
20.44M
0.00%
Strategic partnerships and other
13.71M
0.00%
Other precision diagnostics
6.34M
0.00%

股東統計

更新時間: 1月11日 週日
更新時間: 1月11日 週日
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
11.00%
Janus Henderson Investors
10.08%
The Vanguard Group, Inc.
10.06%
Morgan Stanley & Co. LLC
5.55%
Farallon Capital Management, L.L.C.
5.24%
其他
58.08%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
11.00%
Janus Henderson Investors
10.08%
The Vanguard Group, Inc.
10.06%
Morgan Stanley & Co. LLC
5.55%
Farallon Capital Management, L.L.C.
5.24%
其他
58.08%
股東類型
持股股東
佔比
Investment Advisor
51.50%
Investment Advisor/Hedge Fund
36.38%
Research Firm
8.68%
Hedge Fund
8.11%
Individual Investor
2.40%
Pension Fund
1.78%
Sovereign Wealth Fund
0.77%
Bank and Trust
0.72%
Family Office
0.13%

機構持股

更新時間: 1月1日 週四
更新時間: 1月1日 週四
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
1032
71.64M
108.04%
-15.51M
2025Q3
1018
78.96M
119.07%
-8.67M
2025Q2
1039
82.20M
120.88%
-4.84M
2025Q1
1066
83.20M
120.27%
-2.89M
2024Q4
1033
78.65M
114.86%
-4.64M
2024Q3
1003
73.69M
106.06%
-7.92M
2024Q2
959
71.82M
103.63%
-10.29M
2024Q1
912
71.21M
103.87%
-11.25M
2023Q4
868
73.50M
107.32%
-9.24M
2023Q3
828
74.80M
109.31%
-3.81M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
7.29M
11%
-208.45K
-2.78%
Sep 30, 2025
Janus Henderson Investors
6.68M
10.08%
-254.25K
-3.66%
Sep 30, 2025
The Vanguard Group, Inc.
6.92M
10.44%
+100.16K
+1.47%
Sep 30, 2025
Morgan Stanley & Co. LLC
3.68M
5.55%
+3.18M
+635.59%
Sep 30, 2025
Farallon Capital Management, L.L.C.
3.48M
5.24%
+161.00K
+4.85%
Sep 30, 2025
Fidelity Management & Research Company LLC
3.10M
4.68%
-1.03M
-24.93%
Sep 30, 2025
State Street Investment Management (US)
2.50M
3.77%
-61.59K
-2.41%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.75M
2.65%
-22.43K
-1.26%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.37M
2.07%
-12.04K
-0.87%
Sep 30, 2025
Reinhart Partners, LLC
1.35M
2.03%
-55.90K
-3.98%
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
State Street SPDR S&P Health Care Equipment ETF
1.96%
Invesco S&P MidCap 400 GARP ETF
1.69%
First Trust Small Cap US Equity Select ETF
1.07%
VictoryShares Small Cap Free Cash Flow ETF
0.93%
Invesco S&P MidCap 400 Pure Growth ETF
0.74%
Distillate Small/Mid Cash Flow ETF
0.66%
Pacer US Small Cap Cash Cows ETF
0.56%
Gotham 1000 Value ETF
0.5%
Invesco S&P MidCap Quality ETF
0.47%
Pacer US Cash Cows Growth ETF
0.47%
查看更多
State Street SPDR S&P Health Care Equipment ETF
佔比1.96%
Invesco S&P MidCap 400 GARP ETF
佔比1.69%
First Trust Small Cap US Equity Select ETF
佔比1.07%
VictoryShares Small Cap Free Cash Flow ETF
佔比0.93%
Invesco S&P MidCap 400 Pure Growth ETF
佔比0.74%
Distillate Small/Mid Cash Flow ETF
佔比0.66%
Pacer US Small Cap Cash Cows ETF
佔比0.56%
Gotham 1000 Value ETF
佔比0.5%
Invesco S&P MidCap Quality ETF
佔比0.47%
Pacer US Cash Cows Growth ETF
佔比0.47%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI